Publications of Bork Group in the journal "Aliment Pharmacol Ther".

Publications of Bork Group in the journal "Aliment Pharmacol Ther".

Authors in this color are/were of Bork Group. [Altmetric off].
The manuscripts available on our site are provided for your personal use only and may not be retransmitted or redistributed without written permissions from the paper's publisher and author. You may not upload any of this site's material to any public server, on-line service, network, or bulletin board without prior written permission from the publisher and author. You may not make copies for any commercial purpose. Please email us for any paper request!
2024 1 publication(s).
2.
Terlipressin therapy is associated with increased risk of colonisation with multidrug-resistant bacteria in patients with decompensated cirrhosis.
Mücke MM, Hernández-Tejero M, Gu W, Kuhn M, Janz M, Keller MI, Fullam A, Altepeter L, Mücke VT, Finkelmeier F, Schwarzkopf KM, Cremonese C, Hunyady PM, Heilani MW, Uschner FE, Schierwagen R, Brol MJ, Fischer J, Klein S, Peiffer KH, Hogardt M, Shoaie S, Coenraad MJ, Bojunga J, Arroyo V, Zeuzem S, Kempf VAJ, Welsch C, Laleman W, Bork P, Fernandez J, Trebicka J, MICROB-PREDICT and PREDICT Study Group of the EASL-CLIF Consortium
Aliment Pharmacol Ther.
2024 Apr 27; 59(7): 877-888. PubMed: 38414095.
Abstract + PDF
2021 1 publication(s).
1.
Progressive alcohol-related liver fibrosis is characterised by imbalanced collagen formation and degradation.
Thiele M, Johansen S, Gudmann NS, Madsen B, Kjaergaard M, Nielsen MJ, Leeming DJ, Jacobsen S, Bendtsen F, Møller S, Detlefsen S, Karsdal M, Krag A, GALAXY consortium , Arumugam M, Bork P, Hansen T, Anastasiadou E, Hartoft C, Israelsen H, Legido-Quigley C, Melberg HO, Trebicka J
Aliment Pharmacol Ther.
2021 10; 54(8): 1070-1080. PubMed: 34428307.
Abstract + PDF